Cargando…
Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue
Fluorescence microscopy is widely used for high content screening in 2D cell cultures and 3D models. In particular, 3D tissue models are gaining major relevance in modern drug development. Enabling direct multiparametric evaluation of complex samples, fluorescence lifetime imaging (FLIM) adds a furt...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255044/ https://www.ncbi.nlm.nih.gov/pubmed/32483455 http://dx.doi.org/10.7150/thno.42581 |
_version_ | 1783539656990654464 |
---|---|
author | Brodwolf, Robert Volz-Rakebrand, Pierre Stellmacher, Johannes Wolff, Christopher Unbehauen, Michael Haag, Rainer Schäfer-Korting, Monika Zoschke, Christian Alexiev, Ulrike |
author_facet | Brodwolf, Robert Volz-Rakebrand, Pierre Stellmacher, Johannes Wolff, Christopher Unbehauen, Michael Haag, Rainer Schäfer-Korting, Monika Zoschke, Christian Alexiev, Ulrike |
author_sort | Brodwolf, Robert |
collection | PubMed |
description | Fluorescence microscopy is widely used for high content screening in 2D cell cultures and 3D models. In particular, 3D tissue models are gaining major relevance in modern drug development. Enabling direct multiparametric evaluation of complex samples, fluorescence lifetime imaging (FLIM) adds a further level to intensity imaging by the sensitivity of the fluorescence lifetime to the microenvironment. However, the use of FLIM is limited amongst others by the acquisition of sufficient photon numbers without phototoxic effects in live cells. Herein, we developed a new cluster-based analysis method to enhance insight, and significantly speed up analysis and measurement time for the accurate translation of fluorescence lifetime information into pharmacological pathways. Methods: We applied a fluorescently-labeled dendritic core-multishell nanocarrier and its cargo Bodipy as molecules of interest (MOI) to human cells and reconstructed human tissue. Following the sensitivity and specificity assessment of the fitting-free Cluster-FLIM analysis of data in silico and in vitro, we evaluated the dynamics of cellular molecule uptake and intracellular interactions. For 3D live tissue investigations, we applied multiphoton (mp) FLIM. Owing to Cluster-FLIM's statistics-based fitting-free analysis, we utilized this approach for automatization. Results: To discriminate the fluorescence lifetime signatures of 5 different fluorescence species in a single color channel, the Cluster-FLIM method requires only 170, respectively, 90 counts per pixel to obtain 95% sensitivity (hit rate) and 95% specificity (correct rejection rate). Cluster-FLIM revealed cellular interactions of MOIs, representing their spatiotemporal intracellular fate. In a setting of an automated workflow, the assessment of lysosomal trapping of the MOI revealed relevant differences between normal and tumor cells, as well as between 2D and 3D models. Conclusion: The automated Cluster-FLIM tool is fitting-free, providing images with enhanced information, contrast, and spatial resolution at short exposure times and low fluorophore concentrations. Thereby, Cluster-FLIM increases the applicability of FLIM in high content analysis of target molecules in drug development and beyond. |
format | Online Article Text |
id | pubmed-7255044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-72550442020-05-31 Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue Brodwolf, Robert Volz-Rakebrand, Pierre Stellmacher, Johannes Wolff, Christopher Unbehauen, Michael Haag, Rainer Schäfer-Korting, Monika Zoschke, Christian Alexiev, Ulrike Theranostics Research Paper Fluorescence microscopy is widely used for high content screening in 2D cell cultures and 3D models. In particular, 3D tissue models are gaining major relevance in modern drug development. Enabling direct multiparametric evaluation of complex samples, fluorescence lifetime imaging (FLIM) adds a further level to intensity imaging by the sensitivity of the fluorescence lifetime to the microenvironment. However, the use of FLIM is limited amongst others by the acquisition of sufficient photon numbers without phototoxic effects in live cells. Herein, we developed a new cluster-based analysis method to enhance insight, and significantly speed up analysis and measurement time for the accurate translation of fluorescence lifetime information into pharmacological pathways. Methods: We applied a fluorescently-labeled dendritic core-multishell nanocarrier and its cargo Bodipy as molecules of interest (MOI) to human cells and reconstructed human tissue. Following the sensitivity and specificity assessment of the fitting-free Cluster-FLIM analysis of data in silico and in vitro, we evaluated the dynamics of cellular molecule uptake and intracellular interactions. For 3D live tissue investigations, we applied multiphoton (mp) FLIM. Owing to Cluster-FLIM's statistics-based fitting-free analysis, we utilized this approach for automatization. Results: To discriminate the fluorescence lifetime signatures of 5 different fluorescence species in a single color channel, the Cluster-FLIM method requires only 170, respectively, 90 counts per pixel to obtain 95% sensitivity (hit rate) and 95% specificity (correct rejection rate). Cluster-FLIM revealed cellular interactions of MOIs, representing their spatiotemporal intracellular fate. In a setting of an automated workflow, the assessment of lysosomal trapping of the MOI revealed relevant differences between normal and tumor cells, as well as between 2D and 3D models. Conclusion: The automated Cluster-FLIM tool is fitting-free, providing images with enhanced information, contrast, and spatial resolution at short exposure times and low fluorophore concentrations. Thereby, Cluster-FLIM increases the applicability of FLIM in high content analysis of target molecules in drug development and beyond. Ivyspring International Publisher 2020-05-15 /pmc/articles/PMC7255044/ /pubmed/32483455 http://dx.doi.org/10.7150/thno.42581 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Brodwolf, Robert Volz-Rakebrand, Pierre Stellmacher, Johannes Wolff, Christopher Unbehauen, Michael Haag, Rainer Schäfer-Korting, Monika Zoschke, Christian Alexiev, Ulrike Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue |
title | Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue |
title_full | Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue |
title_fullStr | Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue |
title_full_unstemmed | Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue |
title_short | Faster, sharper, more precise: Automated Cluster-FLIM in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue |
title_sort | faster, sharper, more precise: automated cluster-flim in preclinical testing directly identifies the intracellular fate of theranostics in live cells and tissue |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255044/ https://www.ncbi.nlm.nih.gov/pubmed/32483455 http://dx.doi.org/10.7150/thno.42581 |
work_keys_str_mv | AT brodwolfrobert fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue AT volzrakebrandpierre fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue AT stellmacherjohannes fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue AT wolffchristopher fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue AT unbehauenmichael fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue AT haagrainer fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue AT schaferkortingmonika fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue AT zoschkechristian fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue AT alexievulrike fastersharpermorepreciseautomatedclusterfliminpreclinicaltestingdirectlyidentifiestheintracellularfateoftheranosticsinlivecellsandtissue |